drugset / Trial / NCT05675501

Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties

NCT05675501

Phase 1 Completed 31 enrolled Sol-Gel Technologies, Ltd.
RandomizedCrossoverTriple-blindOther

Summary

The overall objective of this study is to assess how the use of the drug may shift the skin microbiome and skin biophysical properties. Specifically, the study objectives were to assess the following: * How the drug affects the skin microbiome compared with vehicle when applied once daily for 8 weeks in subjects with papulopustular rosacea. * How the drug affects the skin physical properties compared with vehicle when applied once daily for 8 weeks in subjects with papulopustular rosacea.

Timeline

Start
2020-06-10
Primary completion
2021-07-15
Completion
2021-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified Topical

Indications